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Myoﬁbroblasts are essential during wound healing and are often found in the stroma of oral squamous
cell carcinomas (OSCC). Although the molecular mechanisms by which myoﬁbroblasts inﬂuence OSCC
remain largely unknown, previous studies demonstrated that presence of myoﬁbroblast in OSCC stroma
is an important risk factor of patient’s shortened survival. Here we showed that some growth factors are
produced in higher levels by tumor-associated myoﬁbroblasts compared to tumor-associated ﬁbroblasts,
including activin A. Myoﬁbroblast-conditioned media containing activin A signiﬁcantly increased OSCC
cell proliferation and tumor volume, whereas down-regulation of activin A in the conditioned media
decreased proliferation. In addition, myoﬁbroblasts induced in vitro invasion of OSCC cells, which was
accompanied by an increased production of matrix metalloproteinases (MMP). In vivo, a signiﬁcant cor-
relation between presence of myoﬁbroblasts and activities of MMP-2 and MMP-9 was observed in OSCC
samples. However, blockage of activin A synthesis by myoﬁbroblasts did not affect invasion and MMP
production by OSCC cells. Together, our data demonstrate that activin A is required for the proliferative
effects of myoﬁbroblasts on OSCC cells. We conclude that myoﬁbroblasts in the stroma of OSCC may
inﬂuence proliferation and invasion, resulting in more aggressive tumor.
 2011 Elsevier Ltd. Open access under the Elsevier OA license.Introduction
Myoﬁbroblasts secrete extracellular matrix molecules and
degrading enzymes, angiogenic and pro- and anti-inﬂammatory
factors, and stimulate epithelial cell proliferation and invasion.1–3
Myoﬁbroblasts are classically involved in wound healing, but they
are also found in the reactive tumor stroma.4,5 Although the knowl-
edge of myoﬁbroblast participation in tumors is evolving, there has
been little work investigating the role of myoﬁbroblasts in oral
squamous cell carcinomas (OSCC).
The ﬁrst evidence in favor of a role for myoﬁbroblasts in OSCC
was obtained by Barth et al. in 2004,6 and later of this year Lewis
et al.7 demonstrated that myoﬁbroblasts induced by TGF-b1 se-
crete hepatocyte growth factor, which promotes OSCC invasion
in vitro. Clinicopathologic studies demonstrated that myoﬁbro-
blasts in the stroma of OSCC signiﬁcantly correlate with lymph
node metastasis, vascular, lymphatic and perineural invasion of
the tumor cells, and patient’s shorter survival, suggesting that
myoﬁbroblasts may assist tumor invasion and metastasis.8–11
Moreover, it was demonstrated that mutual interactions betweenf Oral Diagnosis, School of
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er OA license.OSCC cells and myoﬁbroblasts may exist, and that conditioned
media from TGF-b1-induced myoﬁbroblasts enhances cell growth
of OSCC cells.12 In this study we examine the role of myoﬁbroblasts
in tumor proliferation and invasion and identify the molecular
mechanism by which myoﬁbroblasts inﬂuence cellular prolifera-
tion. By secretion of activin A, myoﬁbroblasts set in motion a path-
way for proliferation of OSCC cells. We further show that
myoﬁbroblast-released factors, others than activin A, induce inva-
sion and secretion of matrix metalloproteinases (MMP) by OSCC
cells, and that presence of myoﬁbroblasts in OSCCs correlates with
increased tumor production of MMP-2 and MMP-9.Material and methods
Cell cultures
Tumor-associated ﬁbroblast and myoﬁbroblast cell lines were
established from fragments of tongue SCCs using tissue explants
as described previously.13 Cells were maintained in Dulbecco’s
modiﬁed Eagle’s medium (DMEM, Invitrogen, Carlsbad, CA, USA)
containing 10% donor calf serum (DCS) and antibiotics at 37 C in
a 5% CO2 air atmosphere. Individual clones were selected by clon-
ing ring strategy and screened for a-SMA expression by western
blot and ﬂow cytometric analysis,14 for differentiation markers
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ELISA.16 All experiments were performed using cells between the
8th and 15th passages.
SCC9 and SCC25 oral cancer cell lines were obtained from Amer-
ican Type Culture Collection (ATCC, Manassas, VA, USA) and cul-
tured as recommended.
Preparation of the media conditioned by ﬁbroblast and myoﬁbroblast
clones
Subconﬂuent monolayers (2500 cells/cm2) of three ﬁbroblast
clones and two myoﬁbroblast clones were washed twice with
PBS and once with serum-free DMEM, and subsequently cultured
in serum-free DMEM for 24 h. The conditioned media was clariﬁed
by centrifugation, aliquoted and stored at 80 C until used to
determine the effect on tumor cell proliferation or MMP
production.
Proliferation assay
The effect of ﬁbroblast and myoﬁbroblast clones on OSCC cell
proliferation was determined by bromodeoxyuridine (BrdU) incor-
poration index,12 24 h after release from a serum-starved syn-
chrony. BrdU-labeling index, expressed as the percentage of cells
labeled with BrdU, was determined by counting 500 cells in two
independent reactions using the Kontron 400 image analysis sys-
tem (Zeiss).
Invasion assay
The in vitro cell invasion assay was performed by using a mod-
iﬁed Boyden chamber insert with polycarbonate ﬁlter membrane
containing 8-lm pores in 24-well plates (Corning Inc., Corning,
NY, USA). Matrigel (BD Biosciences, San Jose, CA, USA) was diluted
to 1:1 with serum-free media and used to coat the ﬁlter mem-
branes. In the lower chamber, monolayers of ﬁbroblast and myoﬁ-
broblast clones were plated in triplicate and cultured in serum-free
DMEM. Tumor cells (1  105) suspended in 200 ll of serum-free
DMEM/F12 were seeded onto the upper compartment of the trans-
well chamber. After incubation for 72 h, the media in the upper
chamber was removed and the ﬁlters were ﬁxed with 10% formalin
for 15 min. The cells remaining on the upper surface of the ﬁlter
membrane were then completely removed by wiping with a cotton
swab, and the cells on the opposite surface of the ﬁlter membrane
were stained with 1% toluidine blue in 1% borax for 5 min and then
lysed with 1% SDS. Absorbance was read at 650 nm to determine
relative cell number.
Elisa
For MMP quantiﬁcation, OSCC cells were cultured with ﬁbro-
blast or myoﬁbroblast-conditioned media for 24 h. The media were
collected, whereas the cells were ﬁxed and used for cell count by
toluidine blue stain method. In essence, microtite plate wells were
coated with 100 ll of the culture medias for 2 h at room tempera-
ture. The wells were then washed and non-speciﬁc binding sites
were blocked with 3% BSA in PBS for 2 h. After washing, anti-
MMP-1 (diluted 1:10,000), anti-MMP-2 (diluted 1:3500), anti-
MMP-9 (diluted 1:2000), and anti-MMP-13 (1:2000) antibodies
in PBS were added to the wells and incubated for 2 h. All antibodies
were purchased from Calbiochem (Merck KGaA, Darmstadt, Ger-
many). After another washing step, goat anti-mouse peroxidase-
conjugated IgG (Vector Labs, Burlingame, CA, USA) diluted
1:1000 in PBS was added and maintained for 1 h. The reaction
was developed with 0.5 mg/ml of o-phenylenediamine (Sigma) in
0.5 M citric buffer pH 5.5 containing 0.01% H2O2 for 20 min. Afterterminating the reaction with 50 ll of 2 N H2SO4, absorbance
was read at 450 nm. The values were expressed as MMPs/cell.
Real-time PCR array and quantitative real-time PCR
RNA isolation and cDNA synthesis were performed as previ-
ously described.16 cDNAs were used to quantify human growth fac-
tor expression in a 96-well plate array (RT2 Proﬁler™ PCR Array
System, SABiosciences, Qiagen, Frederick, MD, USA), according to
the manufacturer’s instructions. Up- and down-regulated genes
were deﬁned as those whose expression level in myoﬁbroblast
clones was greater or lower than 2-fold that observed in ﬁbroblast
clones, in an average of three independent experiments with two
individual clones for each group.
Quantitative reverse transcription-PCR (qRT-PCR) was per-
formed with the StepOne Plus instrument (Applied Biosystems),
and amplicons were detected by using SYBR green ﬂuorescence
method. Target genes were analyzed by using standard curves to
determine relative levels of gene expression, and individual RNA
samples were normalized according to the levels of GAPDH. All
primers used in this study are described in Supplementary Table 1.
Small interference RNA (siRNA)
siRNA molecules to target INHBA mRNA and nontargeting neg-
ative control were purchased from Invitrogen and transfected as
previously described.17 After transfection, the efﬁcacy of the INHBA
knock down was determined by qRT-PCR and ELISA.
Tumorigenicity assay
To assess the growth of xenographic tumors in nude mice, eight
12 week-old nude mice per cell line were injected s.c. in the ﬂank
with SCC9 cells mixture with either ﬁbroblast clones or myoﬁbro-
blast clones. Tumor size was measured weekly with a calipers, and
volumes are reported as mm3, calculated by using the formula vol-
ume = 0.5  length width2. At 12 week postinjection, all mice
were euthanized, and tumors and multiple organs were examined
grossly, collected, ﬁxed in 10% formalin and then embedded in par-
afﬁn. Five-micrometer sections were stained with H&E for histo-
pathologic analysis.
Immunohistochemistry and zymography
Thirty-three consecutive OSCC samples removed during tumor
resection were divided into two parts: one was ﬁxed in formalin
and embedded in parafﬁn for H&E staining or immunohistochem-
istry against a-SMA,14 while the other was used as tissue culture to
zymographic analysis.18
Statistical analysis
Assays were performed at least three times. The Kruskal–Wallis
multiple comparison test was used to test group effects at 5% sig-
niﬁcance (p < 0.05).
Results
Characterization of the cancer-associated myoﬁbroblast clones
From three tongue SCCs we established several spindle-shaped
cells with indented nuclei that were plated in low density, isolated
with aid of cloning rings and characterized as myoﬁbroblasts by
the expression of a-SMA and elevated type I collagen synthesis.
Western blot analysis revealed an excessive production of a-SMA
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(Fig. 1A). Flow cytometric analysis showed that more than 90% of
the cells express a-SMA in the myoﬁbroblast clones (Fig. 1B). As
a marker of myoﬁbroblast activity, type I collagen production
was evaluated. Myoﬁbroblast clones produced signiﬁcantly higher
amounts of type I collagen than ﬁbroblasts (Fig. 1C). Both ﬁbroblast
and myoﬁbroblast clones were positive for vimentin and negative
for pan-cytokeratin and CD34 (Supplementary Fig. 1). In long time
culture, western blot, ﬂow cytometric analysis and ELISA revealed
constant a-SMA expression and elevated production of type I col-
lagen. Thus, those clones were used to further characterization of
myoﬁbroblast-effects on tumor proliferation and invasion.
Myoﬁbroblasts promote proliferation and enhance tumor volume in
nude mice
The comparative effect of myoﬁbroblast-conditioned media and
ﬁbroblast-conditioned media on OSCC proliferation was assessed
by measuring BrdU incorporation into DNA. Fig. 2A shows that
myoﬁbroblast-conditioned media signiﬁcantly stimulated BrdU-
labeling index of both SCC9 and SCC25 oral cancer cell lines com-
pared to ﬁbroblast-conditioned media (p < 0.001 for SCC9 and
p < 0.05 for SCC25). Interestingly, BrdU-labeling index of both oral
cancer cell lines induced by myoﬁbroblast-conditioned media was
similar to those of the positive control (fresh media containing 10%
of DCS). When myoﬁbroblast cell lines were injected with SCC9
cells into nude mice, tumors formed were signiﬁcantly larger than
those formed by the ﬁbroblast clones and SCC9 (Fig. 2B). Tumors
formed in the presence of the myoﬁbroblast clone 1 were signiﬁ-
cantly larger than controls from week 2 to 12 (p < 0.001), whereas
differences for myoﬁbroblast clone 2 was observed later, fromFigure 1 Characterization of the myoﬁbroblast clones. Individual clones of OSCC-associat
production, and characterized as ﬁbroblast or myoﬁbroblast cell lines. (A) Western blot
expression in the myoﬁbroblasts. (B) Representative ﬂow cytometric analysis showed tha
type I collagen showed that myoﬁbroblast clones produced signiﬁcantly higher amountweek 6 to 12 (p < 0.01). No metastases were observed. As an unin-
spected result, SCC25 cells were not capable to induce tumors
either when injected alone or when injected in association with
ﬁbroblasts or myoﬁbroblasts.
Myoﬁbroblasts induce invasion and synthesis of MMPs, and MMP
activities are correlated with myoﬁbroblasts in vivo
We compared the effect of factors released from ﬁbroblasts and
myoﬁbroblasts on invasion of SCC9 and SCC25 cells. We found that
myoﬁbroblasts signiﬁcantly promoted invasion of SCC9 cells com-
pared with ﬁbroblasts (p < 0.0001, Fig. 3A). Since myoﬁbroblast
clones stimulated invasion of SCC9 cells, we further investigated
whether this event is accompanied by increased MMP production.
Myoﬁbroblast clones signiﬁcantly induced production of MMP-1,
MMP-2, MMP-9, and MMP-13 by SCC9 cells compared with ﬁbro-
blast clones (Fig. 3B). Although myoﬁbroblast clones induced MMP
production by SCC25 cells, those cells were not capable to invade
towards any of the stimuli (data not shown).
To investigate whether myoﬁbroblasts are associated with
highly invasive oral cancers, we used 33 samples of OSCC to exam-
ine myoﬁbroblast presence concurrent with MMP activities. As
previously reported,8 myoﬁbroblasts was detected by immunohis-
tochemistry and scored as undetectable (0), scanty (1), or abun-
dant (2), whereas MMP activities were characterized by gelatin
zymography. Four major gelatinolytic bands were produced by
the tumor samples, a doublet with approximately 66 and 72 kDa,
which correspond to the active and latent forms of MMP-2, and
two more diffuse bands with approximately 85 and 92 kDa corre-
sponding to active and latent forms of MMP-9, respectively. These
activities were attributed to MMPs since they were completelyed mesenchymal fusiform cells were cloned, screened for a-SMA and type I collagen
analysis showed a lack of a-SMA expression in the ﬁbroblast cell lines, and a high
t more than 90% of the cells express a-SMA in the myoﬁbroblast clones. (C) ELISA for
s of type I collagen than ﬁbroblasts (p < 0.01).
Figure 2 Myoﬁbroblast stimulates OSCC proliferation. (A) Myoﬁbroblast-conditioned media signiﬁcantly stimulated BrdU-labeling index of both SCC9 and SCC25 oral cancer
cell lines compared to ﬁbroblast-conditioned media (p < 0.001 for SCC9 and p < 0.05 for SCC25). Negative control represented cells cultivate without FBS, whereas cells
cultured in the presence of 10% FBS were used as positive control. (B) Myoﬁbroblasts signiﬁcantly increases tumor burden in nude mice. SCC9 cells with either ﬁbroblast or
myoﬁbroblast clones were injected into the ﬂank of 12-week-old nude mice, and tumor size was measured over a 12-week time period. Data are shown as mean ± SD. In the
presence of the myoﬁbroblast clone 1, tumors were signiﬁcantly larger than controls from week 2 to 12 (p < 0.001), whereas differences for myoﬁbroblast clone 2 was
observed later, from week 6 to 12 (p < 0.01).
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with abundant presence of myoﬁbroblasts showed signiﬁcantly
higher activities of MMP-2 and MMP-9 compared with tumors
classiﬁed as negative or scanty for myoﬁbroblasts (Fig. 3D). These
data are consistent with the notion that abundant presence of
myoﬁbroblasts results in highly invasive oral tumors.
Myoﬁbroblasts are dependent on activin A secretion to stimulate
proliferation but not invasion of OSCC cells
To gain insight into the molecular mechanism by which myoﬁ-
broblasts affect proliferation and invasion, we examined the
expression proﬁle of growth factors by using a quantitative real-
time PCR array. When the criteria outlined in materials and meth-
ods were used, ﬁve signiﬁcantly up-regulated and four down-reg-
ulated genes were identiﬁed (Table 1). All genes were reproducibly
and signiﬁcantly regulated in myoﬁbroblasts as revealed by qRT-
PCR. In three independent experiments we found up-regulation
of INHBA in myoﬁbroblast clones compared to ﬁbroblast clones,
whereas the levels of INHBB and INHA expression were quite sim-
ilar. As the product of INHBA (activin A) has important role in both
cell cycle and invasion control,19 we focused our attention on acti-
vin A. The amount of activin A was signiﬁcantly higher in the
supernatants of myoﬁbroblast clones compared with ﬁbroblast
clones (Supplementary Fig. 2).
To determine whether myoﬁbroblast-released activin A pro-
motes proliferation and invasion, activin A was knocked down by
using siRNA. When activin A-speciﬁc oligonucleotides were used,
a rapid and signiﬁcant downregulation of activin A mRNA was ob-
served and maintained for 3 days (Fig. 4A). The decrease in activin
A levels was concomitant with a signiﬁcant decrease in the prolif-
eration of both SCC9 and SCC25 cells cultured with myoﬁbroblast-
conditioned media, demonstrating that activin A released by myo-
ﬁbroblasts regulates OSCC cell proliferation (Fig. 4B). On the otherhand, downregulation of activin A on myoﬁbroblast conditioned
media did not alter SCC9 invasion (Fig. 4C). Since SCC9 invasion in-
duced by myoﬁbroblast clones was associated with increased MMP
production, we performed ELISA for all MMPs in the conditioned
media. MMP levels remained constant even in activin A downreg-
ulated cells (Fig. 4D). Together, these data suggest that myoﬁbro-
blast-induced OSCC invasion and MMP synthesis are independent
of activin A.Discussion
Emergence of myoﬁbroblasts is commonly observed in human
cancers. Although through secretion of an extensive repertoire of
molecules these cells are known to affect numerous processes
important in both would healing and ﬁbrosis,20 a causal role for
myoﬁbroblasts in tumor progression remains controversial. The
evidence presented in this article that myoﬁbroblasts secrete sev-
eral growth factors which induce proliferation, invasion and pro-
duction of MMPs in OSCC cells in culture, and that their presence
correlates with indices of MMP-2 and MMP-9 activity in OSCCs,
strongly support a role for these cells on tumor progression and
invasion. Furthermore, our current data, coupled with previously
published work,12 show that myoﬁbroblasts promote proliferative
activity of OSCC by upregulating activin A, a member of the trans-
forming growth factor-b superfamily of proteins.21 Activins are
homo or heterodimeric proteins consisting of two b subunits (bA
and bB), and INHBA is one of the b subunits (bA) that comprise acti-
vin A (bAbA), activin AB (bAbB) and inhibin A (abA).22 Activin A
regulates normal embryogenesis,21 and its dysregulation is ob-
served in endometrial carcinoma,23 testicular cancer,24 esophageal
squamous cell carcinoma,25 and lung adenocarcinoma.26 In the la-
ter, activin A overexpression promotes tumor proliferation and is
associated with worse survival. Thus, elevated expression of IN-
HBA, b subunits of activin A, by stromal myoﬁbroblasts induces
Figure 3 Myoﬁbroblast promotes invasion and MMP synthesis of OSCC cells. (A) SCC9 cells were subjected to transwell chamber invasion assay with factors released by
ﬁbroblast or myoﬁbroblast clones as chemotactics. Myoﬁbroblasts signiﬁcantly promoted invasion of SCC9 cells compared with ﬁbroblasts (p < 0.0001). Cells cultured in the
absence of chemotactic factors in the lower chamber were used as negative control. (B) Myoﬁbroblast-induced SCC9 invasion was associated with increased production of
MMP-1, MMP-2, MMP-9 and MMP-13, as revealed by ELISA (p < 0.001). (C) Zymographic analysis of MMPs secreted by six representative OSCC samples. Gelatinolytic
activities were detected at66–72 kDa and85–92 kDa, consistent with MMP-2 and MMP-9, respectively. Lanes 1, 2, and 6 depict conditioned cell culture media from OSCCs
of the tongue, lane 3 of the retromolar region, and lanes 4 and 5 of the ﬂoor of mouth. Last lane represents sample 6 incubated with 1 mM 1,10-phenanthroline, a speciﬁc
MMP inhibitor. (D) Presence of myoﬁbroblasts [from undetectable (0), scanty (1), and abundant (2)] was signiﬁcantly associated with an increasing in the activity of the
MMP-2 and MMP-9 of the OSCCs (p < 0.05 for MMP-2 and p < 0.008 for MMP-9).
Table 1
Up- and down-regulated genes in myoﬁbroblasts. Values represent the fold of
expression in myoﬁbroblast clones in relation to ﬁbroblast clones. After selection
using the method outlined in materials and methods, genes were validated by qRT-
PCR in three independent experiments.
Genes Real-time PCR array qRT-PCR p Value
Up-regulated
BMP4 7.63 4.45 0.01
FIGF 6.24 3.54 0.013
INHBA 2.09 3.06 0.003
MDK 3.44 1.80 0.007
NTF3 16.53 2.75 0.02
Down-regulated
BMP6 10.70 3.95 0.001
FGF13 7.88 6.45 0.002
GDF10 3.38 9.50 0.03
IL1B 3.65 5.85 0.0003
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prognostic value and may represent an important target for cancer
therapy.26–30 Blockage of activin A expression or its biological
activity with speciﬁc agents, such as follistatin, monoclonal anti-
bodies or small interference RNA molecules, may have a therapeu-
tic potential, however, since activin A is expressed in a wide variety
of human tissues, side effects are expected. To date is proposed
that circulating levels of activin A may distinguish patients with
breast or prostate tumors showing bone metastases than patients
without metastatic diseases.27 Moreover, inhibition of activin Aactivity with soluble activin receptor type IIA fusion protein sup-
pressed osteolytic bone disease and tumor burden and increased
survival in in vivo models of multiple myeloma and breast can-
cer-induced bone disease.29 Thus, the present data support further
investigations of the role of activin A in OSCC as well as its clinical
and therapeutic implications.
Myoﬁbroblasts are known to induce migration and invasion in a
number of contexts both in normal development31 and tumorigen-
esis.3 Such a role for myoﬁbroblasts in tumor progression is sup-
ported by observations that they are critical for invasion and
metastasis of colon and prostate cancer and basal cell carci-
noma,32–34 and are associated with increased lymph node metasta-
sis as well as poor survival in OSCC,8,9 supporting a role for these
cells in invasion and metastasis. Indeed, our in vitro system dem-
onstrated that myoﬁbroblasts induce secretion of MMPs with sub-
sequent increment in OSCC cell invasion. Although we did not
observe organ metastases in the xenographic model, the study
was not designed to examine metastasis, and thus, it remains a
possibility that myoﬁbroblasts not only promote proliferation of
cancer cells but facility tumor invasion and metastasis. This is in
line with previous reports that demonstrated myoﬁbroblasts as
the main source of MMPs in some types of cancers.11,35–37 In ame-
loblastomas, presence of myoﬁbroblasts as a releasing font of
MMP-2 was associated with rupture of the osseous cortical, which
has been considered an important prognostic marker of ameloblas-
toma aggressiveness.38 Thus, myoﬁbroblasts not only promotes
Figure 4 Inhibition of activin A production by myoﬁbroblasts decreases effect on OSCC cell proliferation. (A) Effect of siRNA against INHBA in myoﬁbroblast clone 2 over a 3-
day time course. Cells were exposed to transfectant agent only (mock), siRNA control or siRNA INHBA. qRT-PCR analysis demonstrate that INHBA levels are signiﬁcantly
decreased after introduction of the speciﬁc siRNA oligonucleotides. (B) BrdU incorporation assay demonstrated a statistically signiﬁcant decrease in both SCC9 and SCC25
proliferation when INHBAwas downregulated by siRNA in myoﬁbroblast clone 2 (p < 0.0001 for SCC9 and p < 0.0001 for SCC25). Downregulation of activin A on myoﬁbroblast
clone 2 conditioned media did not alter invasion (C) and MMP production (D) of SCC9 cells.
L.M. Sobral et al. / Oral Oncology 47 (2011) 840–846 845OSCC cell proliferation, but also is likely to contribute to subse-
quent stages of tumor progression.
In summary, myoﬁbroblasts are powerful regulators affecting
many cellular processes involved in tumorigenesis including pro-
liferation, migration, invasion, and neovascularization.39 Here, we
present strong evidences that myoﬁbroblasts in OSCC induce pro-
liferation via secretion of activin A, and promote invasion through-
out secretion of MMPs. Together with recent clinicopathological
studies,8–12 our data suggest that myoﬁbroblast promotes tumori-
genesis in OSCC, supporting its veriﬁcation and monitoring as a
marker of OSCC behavior.
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